News and Comments

Biogen: A Fruitful Collaboration in Gene Therapy. A Small Gene Therapy Firm That You Should Know

  Tuesday, May 17, 2016

COLLABORATIONS  More...

Biogen Idec Pays Elan $3.25 billion For Tysabri. Do We Leave, Or Stay?

  Wednesday, February 06, 2013

 More...

Elan's Choices

  Saturday, April 16, 2011

Biogen Idec (BIIB) announced positive results of a process aimed at Identifying high-risk patients for a life-threatening side effect of prolonged use of the multiple sclerosis drug Tysabri. This test is a necessity because it detects an antibody that points to the presence of the Polyomavirus JC (JC virus), which causes the life-threatening progressive multifocal leukoencephalopathy (PML). This side effect in one per thousand patients has deprived Elan from billions of dollars in expected sales of Tysabri.  More...


Recent Postings


Archive


Tags

Valeant Pharmaceuticals International (VRX) Mirati Therapeutics (MRTX) Human Longevity (HLI) PORTOLA (PTLA) CEMPRA (CEMP) REGULUS (RGLS) Dendreon (DNDN) Micromet (MITI) Global Cell Therapeutics (GBT) AGOS (ARGS) BIOMARIN (BMRN) IDERA (IDRA) Rapamune Ariad (ARIA) AstraZeneca (AZN) Genentech Inovio (INO) Biocryst (BCRX) Velcade (bortezomib) C4 Therapeutics Exelixis (EXEL) Illumina (ILMN) CompuGen (CGEN) Abbott Laboratories (ABT) Sangamo (SGMO) Akebia Therapeutics (AKAB) ISIS (ISIS) Galena (GALE) Sequenom (SQNM) Intercept (ICPT) Ocular Therapeutix (OCUL) NANTKWEST (NK) SERES THERAPEUTICS (MCRB) Bristol-Myers Squibb (BMY) Bellicum (BLCM) Aimmune Therapeutics (AIMT) Editas (EDIT) Onyx (ONXX) PTC Therapeutics (PTCT) Agenus (AGEN CRISPR Therapeutics (CRSP) ADVENTRIX (ANX) Sanofi (SNY) RenenxBio (RGNX) GlycoMimetics (GLYN) Vertex (VRTX) Human Genome Sciences (HGSI) Array Pharmaceuticals (ARRY) VANDA (VNDA) KERYX (KERX) Intrexon (XON) Dynavax (DVAX) Theravance Bio Pharma (TBPH) Incyte (INCY) Revlimid (lenolidamide) KITE (KITE) Xoma (XOMA) Prolor Biotech (PBTH) NEUROCRINE (NBIX) ARGOS (ARGS) Ionis (IONS) Idenix (IDIX) ZALTRAP™ Roche (RHHBY) ARCA (ABIO) Alnylam (ALNY) Sanofi-Aventis (SAN) Amgen (AMGN) Spike Therapeutics (ONCE) OSI (OSIP) Ridaforolimus NEKTAR (NKTR)) TOKAI (TKAOI) Tysabri Elan (ELN) Seattle Genetics (SGEN) Vitae Pharmaceuticals (VTAE) Multiple Myeloma Anacor (ANAC) Endometrial Cancer Advaxis (ADXS) SUNESIS PHARMACEUTICALS (SNSS) Gilead (GILD) Theravance (THRX) Trastuzumab-DM1 Sarepta (SRPT) OncoCyte (OCX) Cytokinetics (CYTK) Auspex (ASPX) Benlysta (belimumab) Alder Biopharmaceuticals (ALDR) Pluristem (PSTI) ACADIA (ACAD) Prosensa (RNA) Regeneron (REGN) Merck (MRK) LEXICON (LXRX) MODERNA ABBVIE (ABBV) ImmunoGen (IMGN) GUARDIAN HEALTH GlaxoSmithKline (GSK) Zerenex Roche (ROCHE) Herceptin Telaprevir AERIE PHARMACEUTICALS NOVOCURE (NVCR) JOUNCE THERAPEUTICS (JNCE) Anadys (ANDS) Adaptimmune (ADAP) Epizyme (EPZM) Jazz Pharmaceuticals (JAZZ) SYNTA (SNTA) Intermune (ITMN) Biogen Idec (BIIB) INNOVIVA (INVA) HALOZYME (HALO) Ziofpharm (ZIOP) JUNO (JUNO) galapagos (GLPG) Agenus (AGEN) Sanofi (SNA)